Drug intelligence / Profile preview

Olimel N12

Development stage
Phase 4
Lead developer
Takeda
Modality
Small Molecules
Administration
Intravenous, Parenteral
01

Overview

Olimel N12 is a high-protein, multi-chamber parenteral nutrition (PN) emulsion developed by Baxter. It is specifically formulated to meet the high protein requirements of critically ill patients or those with protein-energy wasting, such as patients undergoing hemodialysis. The product is delivered in a triple-chamber bag containing amino acids with electrolytes, a glucose solution with calcium, and a lipid emulsion consisting of a mixture of refined olive oil and soybean oil. The "N12" designation indicates a nitrogen content of approximately 12 grams per liter, providing a high amino acid concentration (76 g/L) relative to its energy content, which helps in maintaining lean tissue mass and supporting recovery in hypercatabolic states.

Brand names
Olimel N12Olimel N12E
Other names
Olimel 7.6%Olimel N12 parenteral nutrition

Beyond the preview

Go deeper on Olimel N12.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Olimel N12.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call